12.5 Results of PBT and vPvB Assessment

This section provides the results of the assessment of Persistent, Bioaccumulative and Toxic (PBT) and very Persistent and very Bioaccumulative (vPvB) properties of substances. This assessment is crucial for identifying substances that may pose long-term risks to the environment due to their persistence, tendency to accumulate in organisms, and toxicity.

PBT and vPvB Overview

PBT and vPvB substances are of particular concern because they:

  • Persist in the environment: Remain intact for long periods
  • Bioaccumulate: Accumulate in living organisms and can biomagnify through the food chain
  • Are toxic (PBT only): Cause adverse effects to human health or the environment
  • Can be transported long distances: May be found far from their sources
  • Are difficult to remove once released: Cannot be easily remediated

Substances identified as PBT or vPvB may be subject to authorization or restriction under REACH and may require specific risk management measures to minimize releases to the environment.

Regulatory Framework

The PBT and vPvB assessment is required under several regulatory frameworks:

  • REACH Regulation (EC) No 1907/2006: Annex XIII sets criteria for PBT and vPvB identification
  • Biocidal Products Regulation (EU) No 528/2012: Requires PBT assessment for active substances
  • Plant Protection Products Regulation (EC) No 1107/2009: Includes PBT criteria for approval of active substances
  • Stockholm Convention on Persistent Organic Pollutants (POPs): International agreement on persistent organic pollutants
  • Water Framework Directive (2000/60/EC): Identifies priority hazardous substances

PBT and vPvB Criteria

Under REACH Annex XIII, the criteria for PBT and vPvB identification are:

Property PBT Criteria vPvB Criteria
Persistence (P/vP)
  • Half-life > 60 days in marine water, or
  • Half-life > 40 days in fresh water, or
  • Half-life > 180 days in marine sediment, or
  • Half-life > 120 days in freshwater sediment, or
  • Half-life > 120 days in soil
  • Half-life > 60 days in marine or fresh water, or
  • Half-life > 180 days in marine or freshwater sediment, or
  • Half-life > 180 days in soil
Bioaccumulation (B/vB) BCF > 2000 BCF > 5000
Toxicity (T)
  • NOEC or EC10 < 0.01 mg/L for marine or freshwater organisms, or
  • Substance is carcinogenic (Cat. 1A or 1B), mutagenic (Cat. 1A or 1B), or toxic for reproduction (Cat. 1A, 1B, or 2), or
  • Evidence of chronic toxicity (STOT RE Cat. 1 or 2), or
  • Endocrine disrupting properties with adverse effects
Not applicable

Assessment Approach

The PBT/vPvB assessment follows a weight-of-evidence approach using expert judgment, considering all available relevant information:

  • Screening assessment: Initial evaluation based on readily available data
  • Definitive assessment: Comprehensive evaluation using high-quality data
  • Integrated assessment: Consideration of all available information in a weight-of-evidence approach

Assessment Sequence:

  1. Gather all available data on P, B, and T properties
  2. Evaluate persistence (P/vP) against criteria
  3. If potentially P/vP, evaluate bioaccumulation (B/vB)
  4. If potentially P/vP and B/vB, evaluate toxicity (T) for PBT assessment
  5. Draw conclusions on PBT and vPvB status

Example: PBT/vPvB Assessment Results

Property Data Criteria Conclusion
Persistence
  • Ready biodegradability: 65% degradation in 28 days (OECD 301B)
  • Half-life in water: 15-25 days
  • Half-life in soil: 30-45 days
  • Half-life in sediment: 45-60 days
  • P: Half-life > 40 days (fresh water)
  • vP: Half-life > 60 days (water)
Not P/vP
Bioaccumulation
  • Log Kow: 3.2
  • BCF (fish): 250 L/kg
  • Metabolism: Moderate
  • B: BCF > 2000
  • vB: BCF > 5000
Not B/vB
Toxicity
  • Fish NOEC (28d): 1.2 mg/L
  • Daphnia NOEC (21d): 0.8 mg/L
  • Algae ErC10: 2.5 mg/L
  • Not CMR, STOT RE, or ED
  • T: NOEC < 0.01 mg/L or
  • CMR, STOT RE, or ED properties
Not T
Overall Conclusion The substance does not meet the criteria for PBT or vPvB.

Assessment Details

Test Methods Used

  • Persistence:
    • OECD 301B: Ready Biodegradability - CO2 Evolution Test
    • OECD 308: Aerobic and Anaerobic Transformation in Aquatic Sediment Systems
    • OECD 307: Aerobic and Anaerobic Transformation in Soil
  • Bioaccumulation:
    • OECD 305: Bioaccumulation in Fish: Aqueous and Dietary Exposure
    • OECD 107: Partition Coefficient (n-octanol/water): Shake Flask Method
  • Toxicity:
    • OECD 210: Fish, Early-life Stage Toxicity Test
    • OECD 211: Daphnia magna Reproduction Test
    • OECD 201: Freshwater Alga and Cyanobacteria, Growth Inhibition Test

Data Reliability

The reliability of data used in the PBT/vPvB assessment is evaluated using the Klimisch scoring system:

  • Klimisch 1: Reliable without restrictions (GLP studies, standardized guidelines)
  • Klimisch 2: Reliable with restrictions (non-GLP studies, non-standard methods but well-documented)
  • Klimisch 3: Not reliable (significant methodological deficiencies)
  • Klimisch 4: Not assignable (insufficient documentation)

For this assessment, only data with Klimisch scores of 1 or 2 were used for the definitive evaluation. Where multiple studies were available, a weight-of-evidence approach was applied, giving preference to higher quality studies.

Uncertainties and Limitations

  • Experimental variability: Test results may vary between laboratories and test conditions
  • Extrapolation: Laboratory tests may not fully represent environmental conditions
  • Metabolites: Transformation products may have different properties than the parent compound
  • Complex substances: For UVCBs and multi-constituent substances, assessment is more challenging
  • Field data limitations: Environmental monitoring data may be limited or absent

The assessment is based on currently available data and may be subject to revision if new information becomes available.

Regulatory Context

  • REACH requirements: PBT/vPvB assessment is mandatory for substances manufactured or imported at ≥ 10 tonnes/year
  • Applicable thresholds: The assessment applies to the substance itself, its constituents, and relevant transformation products
  • Compliance status: The substance does not meet PBT or vPvB criteria and is not subject to authorization based on these properties
  • Risk management implications: Standard risk management measures are sufficient; no specific PBT/vPvB-related measures required

Implications of PBT/vPvB Status

If a substance were identified as PBT or vPvB, the following would apply:

Recent Developments in PBT/vPvB Assessment

Quality Assurance Checklist

  • Verify that all relevant data for P, B, and T assessment has been considered
  • Ensure that the assessment follows the criteria in REACH Annex XIII
  • Check that the data quality and reliability have been evaluated
  • Confirm that a weight-of-evidence approach has been applied
  • Verify that the conclusion is clearly stated and justified
  • Ensure that any uncertainties or data gaps are acknowledged